William Geist - 15 Aug 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
PRESIDENT, PROTEIN SCIENCES
Signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
15 Aug 2024
Net transactions value
$0
Form type
4
Filing time
19 Aug 2024, 17:29:05 UTC
Previous filing
05 Feb 2024
Next filing
05 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TECH Common Stock 4,439 15 Aug 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Performance Restricted Stock Units Award $0 +15,738 $0.000000 15,738 15 Aug 2024 Common Stock 15,738 Direct F2, F10
transaction TECH Restricted Stock Units Award $0 +7,869 $0.000000 7,869 15 Aug 2024 Common Stock 7,869 Direct F2, F11
transaction TECH Stock Options (Right to Buy) Award $0 +21,204 $0.000000 21,204 15 Aug 2024 Common Stock 21,204 $74.91 Direct F12
holding TECH Restricted Stock Units 3,320 15 Aug 2024 Common Stock 3,320 Direct F2, F3
holding TECH Stock Options (Right to Buy) 15,912 15 Aug 2024 Common Stock 15,912 $100.39 Direct F4
holding TECH Performance Restricted Stock Units 7,140 15 Aug 2024 Common Stock 7,140 Direct F2, F5
holding TECH Performance Stock Options (Right to Buy) 22,200 15 Aug 2024 Common Stock 22,200 $94.52 Direct F5
holding TECH Stock Options (Right to Buy) 29,600 15 Aug 2024 Common Stock 29,600 $94.52 Direct F6
holding TECH Performance Restricted Stock Units 9,074 15 Aug 2024 Common Stock 9,074 Direct F2, F7
holding TECH Performance Stock Options (Right to Buy) 24,424 15 Aug 2024 Common Stock 24,424 $84.61 Direct F7
holding TECH Stock Options (Right to Buy) 30,059 15 Aug 2024 Common Stock 30,059 $84.61 Direct F8
holding TECH Restricted Stock Units 19,823 15 Aug 2024 Common Stock 19,823 Direct F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3,320 restricted stock units previously reported in Table I have been moved to Table II and the Reporting Person's beneficial ownership has been updated accordingly.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3 3,320 restricted stock units vest on 2/1/2025.
F4 Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026.
F5 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
F9 9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.
F10 Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11 2,623 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
F12 Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.